WORK Medical’s Neologics enter $114,000 service contract

WORK Medical (WOK) Technology Group announced that its subsidiary, Neologics Bioscience, entered into a key service agreement. his move is not only a significant milestone in WORK Medical’s global expansion strategy and business diversification initiatives, but also signals a pivotal shift in the company’s strategy-moving efficiently from capital injection to research and development execution. Pursuant to the Agreement, Neologics agrees to serve as an independent contractor to provide specified testing services for GemPharmatech. These services will cover the entire process from material preparation, serum titer analysis, hybridoma fusion and screening, antibody sequencing and production, to in vitro validation for several purified recombinant antibodies, as requested by GemPharmatech during the term of the Agreement. As consideration, GemPharmatech has agreed to pay $114,000 in total to Neologisc for the services rendered under the work orders associated with the Agreement.